)
)
BioLineRx Investor Relations Material
Latest events
Q3 2024
BioLineRx
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from BioLineRx Ltd
Access all reports
BioLineRx Ltd. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapeutics for oncology and rare diseases. The company's primary product pipeline includes therapies aimed at treating multiple myeloma, sickle cell disease, pancreatic cancer, and other solid tumors. BioLineRx leverages extensive drug development expertise to advance these therapies from preclinical stages through to commercialization. The company is headquartered in Hevel Modi'in, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
BLRX
Country
🇺🇸 United States